228 related articles for article (PubMed ID: 29722184)
1. Synthesis and antibacterial activities of novel pleuromutilin derivatives bearing an aminothiophenol moiety.
Zhang ZS; Huang YZ; Luo J; Jin Z; Liu YH; Tang YZ
Chem Biol Drug Des; 2018 Sep; 92(3):1627-1637. PubMed ID: 29722184
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Antibacterial Activity Against MRSA of Pleuromutilin Derivatives Possessing a Mercaptoethylamine Linker.
Zhang ZS; Huang YZ; Luo J; Wang BF; Jin Z; Liu YH; Tang YZ
Med Chem; 2018; 14(6):585-594. PubMed ID: 29663895
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and antibacterial evaluation of novel pleuromutilin derivatives possessing piperazine linker.
Gao ML; Zeng J; Fang X; Luo J; Jin Z; Liu YH; Tang YZ
Eur J Med Chem; 2017 Feb; 127():286-295. PubMed ID: 28068600
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker.
Jin Z; Wang L; Gao H; Zhou YH; Liu YH; Tang YZ
Eur J Med Chem; 2019 Nov; 181():111594. PubMed ID: 31419741
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome.
Huang SY; Wang X; Shen DY; Chen F; Zhang GY; Zhang Z; Li K; Jin Z; Du D; Tang YZ
Bioorg Med Chem; 2021 May; 38():116138. PubMed ID: 33857737
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel pleuromutilin derivatives with a substituted pyrimidine moiety.
Yi Y; Yang G; Zhang C; Chen J; Liang J; Shang R
Eur J Med Chem; 2015 Aug; 101():179-84. PubMed ID: 26134552
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents.
Chai F; Wang J; Zhou KX; Wang SK; Liu YH; Jin Z; Tang YZ
Bioorg Chem; 2022 Sep; 126():105859. PubMed ID: 35605553
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Activity Evaluation of Novel Heterocyclic Pleuromutilin Derivatives.
Yi Y; Fu Y; Dong P; Qin W; Liu Y; Liang J; Shang R
Molecules; 2017 Jun; 22(6):. PubMed ID: 28617344
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and structure-activity relationship studies of novel pleuromutilin derivatives having a piperazine ring.
Luo J; Yang QE; Yang YY; Tang YZ; Liu YH
Chem Biol Drug Des; 2016 Nov; 88(5):699-709. PubMed ID: 27273921
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activities of novel pleuromutilin derivatives.
Yi Y; Fu Y; Wang K; Shui Y; Cai J; Jia Z; Niu B; Liang J; Shang R
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800155. PubMed ID: 30058185
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Pharmacological Evaluation of Novel Pleuromutilin Derivatives with Substituted Benzimidazole Moieties.
Ai X; Pu X; Yi Y; Liu Y; Xu S; Liang J; Shang R
Molecules; 2016 Nov; 21(11):. PubMed ID: 27834819
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel pleuromutilin derivatives as potent antibacterial agents.
Zhou Y; Yi Y; Wang J; Yang Z; Liu Q; Pu W; Shang R
Eur J Med Chem; 2022 Jul; 237():114403. PubMed ID: 35472849
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel pleuromutilin derivatives containing piperazine and 1,2,3-triazole linker.
Zhang GY; Zhang Z; Li K; Liu J; Li B; Jin Z; Liu YH; Tang YZ
Bioorg Chem; 2020 Dec; 105():104398. PubMed ID: 33137559
[TBL] [Abstract][Full Text] [Related]
14. Novel pleuromutilin derivatives with substituted 6-methylpyrimidine: Design, synthesis and antibacterial evaluation.
Fan Y; Liu Y; Wang H; Shi T; Cheng F; Hao B; Yi Y; Shang R
Eur J Med Chem; 2020 Dec; 207():112735. PubMed ID: 32827940
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological activities, and docking study of novel chalcone-pleuromutilin derivatives.
Xie C; Zhang S; Zhang W; Wu C; Yong C; Sun Y; Zeng Z; Zhang Q; Huang Z; Chen T; Zhang Y
Chem Biol Drug Des; 2020 Aug; 96(2):836-849. PubMed ID: 32271987
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker.
Liu J; Zhang GY; Zhang Z; Li B; Chai F; Wang Q; Zhou ZD; Xu LL; Wang SK; Jin Z; Tang YZ
Bioorg Chem; 2021 Jul; 112():104956. PubMed ID: 33991838
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Antibacterial Activity of Novel Pleuromutilin Derivatives.
Liu H; Xiao S; Zhang D; Mu S; Zhang L; Wang X; Xue F
Biol Pharm Bull; 2015; 38(7):1041-8. PubMed ID: 26133714
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo.
Li B; Zhang Z; Zhang JF; Liu J; Zuo XY; Chen F; Zhang GY; Fang HQ; Jin Z; Tang YZ
Eur J Med Chem; 2021 Nov; 223():113624. PubMed ID: 34153574
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activities of novel pleuromutilin derivatives with a substituted pyrimidine moiety.
Yi Y; Xu X; Liu Y; Xu S; Huang X; Liang J; Shang R
Eur J Med Chem; 2017 Jan; 126():687-695. PubMed ID: 27940400
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activities of novel pleuromutilin derivatives with a substituted thiadiazole moiety as potent drug-resistant bacteria inhibitors.
Shang R; Pu X; Xu X; Xin Z; Zhang C; Guo W; Liu Y; Liang J
J Med Chem; 2014 Jul; 57(13):5664-78. PubMed ID: 24892980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]